Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 5, 2024Frontiers in OncologyOpen Access

Harnessing the potential of long non-coding RNAs in breast cancer: from etiology to treatment resistance and clinical applications

View Full Paper
Ask AI
Bookmark
Share

Authors

YWYun WangNBNa BuXLXiao-fei Luan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e75a06b6db6435876d1286https://doi.org/10.3389/fonc.2024.1337579
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer2003 · 152 citations
  2. 2<scp>LncRNA HOTAIR</scp> enhances breast cancer radioresistance through facilitating <scp>HSPA1A</scp> expression via sequestering <scp>miR</scp>‐449b‐5p2020 · 78 citations
  3. 3LINC00478-derived novel cytoplasmic lncRNA LacRNA stabilizes PHB2 and suppresses breast cancer metastasis via repressing MYC targets2023 · 19 citations
  4. 4Long Non-Coding RNAs in the Cytoplasm2016 · 445 citations
  5. 5Divergent Activity of the Pseudogene PTENP1 in ER-Positive and Negative Breast Cancer2017 · 31 citations